Search
Type
Audience
Category
Issue
Last updated
Recall class
Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archive checkbox.
Displaying 1 - 15 of 848 items.
UPDATE: February 7, 2023
One lot of APO-Amitriptyline recalled due to a nitrosamine impurity
Apotex Inc. is recalling one lot of APO-Amitriptyline (lot PY1904) 10 mg tablets due to the presence of N-nitrosodimethylamine (NDMA), a nitrosamine…
AlertPublic advisory | 2023-02-07
Health Canada is warning that intraocular lenses are not licensed to replace a patient’s natural, healthy lens (without cataracts) and that their use for this purpose comes with risks that may outweigh the benefits.
Entities such as surgical eye…
AlertPublic advisory | 2023-02-03
Affected lots may contain the presence of Cronobacter contamination.
RecallHealth product recall | 2023-02-02
Affected lots may contain the presence of foreign matter.
RecallHealth product recall | 2023-01-31
Health Canada is advising about unauthorized health products that may pose serious health risks. The table is updated when Health Canada finds unauthorized health products that are promoted for sexual enhancement, weight loss, as a workout aid, as "…
AlertPublic advisory | 2023-01-25
UPDATED INFORMATION – January 20, 2023
On January 10, 2023, following a Federal Court of Appeal decision, the June 24, 2021 decision of the Minister of Health on the application of the data protection provisions was restored, and a new Notice of…
AlertHealth professional risk communication | 2023-01-20
Health Canada removed various unauthorized health products from sale from More to Shoppe, an online Facebook store, and from its warehouse in Edson, Alberta. The products are labelled to contain prescription drugs and may pose serious health risks.…
AlertPublic advisory | 2023-01-20
Presence of particulate matter in affected lot.
RecallHealth product recall | 2023-01-18
UPDATED INFORMATION – 2023/01/17
Neutralization data for the following SARS-CoV-2 Omicron subvariants have been added to the Canadian Product Monograph: Omicron BA.2.75.2, BF.7, BJ.1, BN.1, BQ.1, BQ.1.1, and XBB. See Table 1 (below) for a summary…
AlertHealth professional risk communication | 2023-01-17
Gas cylinders containing commercial grade oxygen instead of medical grade oxygen were delivered to homecare customers.
RecallHealth product recall | 2022-12-22
The concentration of the medicinal ingredient, sodium fluoride, is out of specification in the affected lot.
RecallHealth product recall | 2022-12-15
Affected lot may result in a false negative for skin test (peanut allergy).
RecallHealth product recall | 2022-12-14
Product sterility may be compromised in the affected lot.
RecallHealth product recall | 2022-12-14
On December 9, 2022, Health Canada authorized a new formulation of the bivalent vaccine, COMIRNATY Original & Omicron BA.4/BA.5, as a booster dose for active immunization against coronavirus disease 2019 (COVID-19) caused by severe acute respiratory…
AlertHealth professional risk communication | 2022-12-09
Affected lot contains active ingredient (Cholecalciferol) levels outside of the labelled claim.
RecallHealth product recall | 2022-12-08